Literature DB >> 17114290

Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

Kitt Falk Petersen1, Sylvie Dufour, Jing Feng, Douglas Befroy, James Dziura, Chiara Dalla Man, Claudio Cobelli, Gerald I Shulman.   

Abstract

Type 2 diabetes mellitus (T2DM) is strongly associated with obesity in most, but not all, ethnic groups, suggesting important ethnic differences in disease susceptibility. Although it is clear that insulin resistance plays a major role in the pathogenesis of T2DM and that insulin resistance is strongly associated with increases in hepatic (HTG) and/or intramyocellular lipid content, little is known about the prevalence of insulin resistance and potential differences in intracellular lipid distribution among healthy, young, lean individuals of different ethnic groups. To examine this question, 482 young, lean, healthy, sedentary, nonsmoking Eastern Asians (n = 49), Asian-Indians (n = 59), Blacks (n = 48), Caucasians (n = 292), and Hispanics (n = 34) underwent an oral glucose tolerance test to assess whole-body insulin sensitivity by an insulin sensitivity index. In addition, intramyocellular lipid and HTG contents were measured by using proton magnetic resonance spectroscopy. The prevalence of insulin resistance, defined as the lower quartile of insulin sensitivity index, was approximately 2- to 3-fold higher in the Asian-Indians compared with all other ethnic groups, and this could entirely be attributed to a 3- to 4-fold increased prevalence of insulin resistance in Asian-Indian men. This increased prevalence of insulin resistance in the Asian-Indian men was associated with an approximately 2-fold increase in HTG content and plasma IL-6 concentrations compared with Caucasian men. These data demonstrate important ethnic and gender differences in the pathogenesis of insulin resistance in Asian-Indian men and have important therapeutic implications for treatment of T2DM and for the development of steatosis-related liver disease in this ethnic group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114290      PMCID: PMC1693873          DOI: 10.1073/pnas.0608537103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.

Authors: 
Journal:  Lancet       Date:  2004-01-10       Impact factor: 79.321

2.  A short questionnaire for the measurement of habitual physical activity in epidemiological studies.

Authors:  J A Baecke; J Burema; J E Frijters
Journal:  Am J Clin Nutr       Date:  1982-11       Impact factor: 7.045

3.  Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.

Authors:  Kitt Falk Petersen; Elif Arioglu Oral; Sylvie Dufour; Douglas Befroy; Charlotte Ariyan; Chunli Yu; Gary W Cline; Alex M DePaoli; Simeon I Taylor; Phillip Gorden; Gerald I Shulman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 4.  Insulin resistance as the core defect in type 2 diabetes mellitus.

Authors:  Barry J Goldstein
Journal:  Am J Cardiol       Date:  2002-09-05       Impact factor: 2.778

5.  Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

Authors:  Mandeep Bajaj; Swangjit Suraamornkul; Thongchai Pratipanawatr; Lou J Hardies; Wilailak Pratipanawatr; Leonard Glass; Eugenio Cersosimo; Yoshinori Miyazaki; Ralph A DeFronzo
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

6.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Douglas Befroy; Rina Garcia; Gerald I Shulman
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

7.  A microfluorometric method for the determination of free fatty acids in plasma.

Authors:  J Miles; R Glasscock; J Aikens; J Gerich; M Haymond
Journal:  J Lipid Res       Date:  1983-01       Impact factor: 5.922

8.  Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.

Authors:  Hyo-Jeong Kim; Takamasa Higashimori; So-Young Park; Hyejeong Choi; Jianying Dong; Yoon-Jung Kim; Hye-Lim Noh; You-Ree Cho; Gary Cline; Young-Bum Kim; Jason K Kim
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

9.  Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

Authors:  Varman T Samuel; Zhen-Xiang Liu; Xianqin Qu; Benjamin D Elder; Stefan Bilz; Douglas Befroy; Anthony J Romanelli; Gerald I Shulman
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

10.  Insulin resistance and vascular dysfunction in nondiabetic Asian Indians.

Authors:  Annaswamy Raji; Marie D Gerhard-Herman; Mercedes Warren; Stuart G Silverman; Vassilios Raptopoulos; Christos S Mantzoros; Donald C Simonson
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  151 in total

1.  Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Naoki Kumashiro; Derek M Erion; Dongyan Zhang; Mario Kahn; Sara A Beddow; Xin Chu; Christopher D Still; Glenn S Gerhard; Xianlin Han; James Dziura; Kitt Falk Petersen; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance.

Authors:  Guglielmo M Trovato; Giuseppe Fabio Martines; Francesca M Trovato; Clara Pirri; Patrizia Pace; Adriana Garozzo; Angelo Castro; Daniela Catalano
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

Review 3.  Fatty liver disease in children--what should one do?

Authors:  Kristin S Bramlage; Vivek Bansal; Stavra A Xanthakos; Rohit Kohli
Journal:  Indian J Pediatr       Date:  2012-06-22       Impact factor: 1.967

Review 4.  The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.

Authors:  François R Jornayvaz; Varman T Samuel; Gerald I Shulman
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 5.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

Review 6.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

7.  Hepatobiliary quiz-7 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-09

8.  Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; João-Paulo G Camporez; Romy Kursawe; Paul M Titchenell; Dongyan Zhang; Curtis J Perry; Michael J Jurczak; Abulizi Abudukadier; Myoung Sook Han; Xian-Man Zhang; Hai-Bin Ruan; Xiaoyong Yang; Sonia Caprio; Susan M Kaech; Hei Sook Sul; Morris J Birnbaum; Roger J Davis; Gary W Cline; Kitt Falk Petersen; Gerald I Shulman
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

9.  Lean NAFLD: An Underrecognized Outlier.

Authors:  Julia Wattacheril; Arun J Sanyal
Journal:  Curr Hepatol Rep       Date:  2016-04-14

10.  Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits.

Authors:  Goro Tsuruta; Naoki Tanaka; Minoru Hongo; Michiharu Komatsu; Akira Horiuchi; Kaeko Hamamoto; Chieko Iguchi; Yoshiko Nakayama; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2010-01-19       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.